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Lymphoscintigraphy is a nuclear medicine procedure that is used to detect sentinel lymph nodes (SLNs). This project sought
to investigate fusion of planar scintigrams with CT topograms as a means of improving the anatomic reference for the SLN
localization. Heretofore, the most common lymphoscintigraphy localization method has been backlighting with a 57Co sheet
source. Currently, the most precise method of localization through hybrid SPECT/CT increases the patient absorbed dose by a
factor of 34 to 585 (depending on the specific CT technique factors) over the conventional 57Co backlighting. The new approach
described herein also uses a SPECT/CT scanner, which provides mechanically aligned planar scintigram and CT topogram data
sets, but only increases the dose by a factor of two over that from 57Co backlighting. Planar nuclear medicine image fusion with CT
topograms has been proven feasible and oﬀers a clinically suitable compromise between improved anatomic details and minimally
increased radiation dose.
1. Introduction
An essential step in the procedure for sentinel lymph node
(SLN) biopsy is to locate the first-echelon node of the drain-
age basin. Lymphoscintigraphy is a minimally invasive diag-
nostic tool for mapping the SLN. After injecting the patient
with sulfur colloid radiolabeled with 99mTc in locations
proximal to a tumor site and waiting for lymphatic drainage
to occur, the lymphatic drainage pathway from the primary
injection site may be imaged with a gamma camera [1].
Interpretation of lymphoscintigrams is hindered by the
absence of anatomical landmarks in the scintigraphy image.
To partly cope with this limitation, it is customary to acquire
additional transmission images via a backlighting 57Co sheet
source in order to facilitate the anatomic localization of the
nodes seen on the scintigraphy image. While the backlighting
imaging technique creates an outline of the patient’s body, it
depicts no internal landmarks.
The introduction of hybrid single photon emission com-
puted tomography with computed tomography (SPECT/CT)
systems into clinical practice presents an opportunity to
improve the spatial localization in lymphoscintigraphy [2].
Improvement in the localization technique could potentially
help the surgeon prepare for sentinel node biopsy (SNB)
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operations, for example, when SLNs lie in the internal
mammary chain where bony anatomy necessitates pinpoint-
ing the location of a node before incision. Single photon
emission computed tomography and computed tomography
image fusion (known as SPECT/CT) provides accurate three-
dimensional (3D) localization of lymph nodes at the cost of
a significant increase in the absorbed dose to the patient for
the overall lymphoscintigraphy and CT procedure. At M.D.
Anderson Cancer Center (MDACC), SPECT/CT is routinely
performed for lymphoscintigraphy of the head and neck
because of the intricate anatomy. For those situations in
which planar scintigrams would suﬃce, we have developed
a technique for fusing the CT topograms (also known as the
CT “scout” or pilot image) with planar lymphoscintigrams
in order to improve the localization of SLNs with better
anatomical information than would be oﬀered by 57Co
backlighting, but with less absorbed dose to the patient than
would be imparted by CT localization.
Conventional Method for Node Localization—57Co
Backlighting: the most common and traditional localization
method for breast lymphoscintigraphy is the use of a low-
activity 57Co sheet source to backlight the patient (Figure 1)
[1, 3, 4]. Following the acquisition of a ten-minute static
anterior emission image, a 57Co sheet source is placed below
the patient on the frame of the posterior camera of a dual-
head gamma camera. A three-minute static anterior patient
silhouette (or backlit) image is acquired that allows the
physician to locate the node in relation to the outline of
the patient. Such an approach aids in assessing whether
lymphatic vessels from the tumor site in the breast are
draining to the internal mammary nodal basin or to the
axillary nodal basin.
A lateral emission image is used to estimate the anterior
depth of the node. The technical details of acquiring the
lateral images vary among institutions. One approach is to
use a chair positioned adjacent to the bed to prop the sheet
source vertically next to the patient [1, 5–7]. In another case,
the source is placed on top of the detector of the gamma
camera below the patient for both the anterior and lateral
images because the lateral images are acquired by rotating
the patient to a lateral decubitus position while leaving the
gamma camera gantry in the “zero-degree” orientation.
The absorbed dose to the patient is kept low by placing
a 57Co sheet source of relatively low activity, 74–185 MBq
(2–5 mCi), on the distal side of the patient for a maximum
of two to three minutes, which provides suﬃcient photon
fluence to obtain an adequate outline of the patient. Clarke,
Notghi, and Harding reported that 57Co backlighting adds
approximately 25% to the absorbed dose to the patient from
a 99mTc-nanocolloid injection [8].
SPECT/CT for Lymphoscintigraphy: the great promise
of hybrid SPECT/CT [9] and PET/CT [10] cameras is
the mechanical registration of emission data with a highly
detailed X-ray computed tomogram, thereby combining
the sensitivity and specificity of a radiopharmaceutical
study with the high resolution morphological information
of a CT scan. The value of SPECT/CT for SLN iden-
tification and localization has been described in several
reports [11–14]. In special instances, SPECT imaging allows
for improved detectability and interpretation of lymphatic
drainage. Contamination, nodes close to the injection site,
and overweight patients are three noted instances in which
SLN identification and localization are better with SPECT
than with standard planar methods [15, 16]. Overall, the
detectability studies comparing planar imaging and SPECT
for the general population do not indicate a compelling
reason to migrate to SPECT for breast lymphoscintigraphy
studies. This is in contrast to protocols such as head and neck
lymphoscintigraphy that nearly always greatly benefit from
using SPECT/CT for SLNs identification and localization, for
example, because the anatomy in that area is much more
complex than that of the breast [17].
2. Materials and Methods
The development of our topogram fusion technique began
with a retrospective chart review that was used as a guide
toward the design and implementation of a phantom that
would realistically mimic a patient undergoing a breast lym-
phoscintigraphic exam. Topograms of a simple alignment
phantom were analyzed to assess the spatial distortion eﬀects
of the fan-beam projection geometry. A protocol to acquire
and process topograms and scintigrams in anteroposterior
and lateral views was implemented. A computer program was
written to process and prepare both topogram and scinti-
gram prior to their fusion. Phantom data were acquired,
prepared, and fused for the characterization and validation
of our approach. In addition, data were acquired and doses
calculated to estimate the absorbed doses to patients from
the 57Co-backlighting, topogram fusion, and SPECT/CT
approaches, respectively.
2.1. Retrospective Chart Review. A retrospective review of
lymphoscintigrams of 200 patients was approved by the
Institutional Review Board (IRB) at U. T. M. D. Anderson
Cancer Center, where the study was conducted. Although
physiological processes vary from individual to individual
(aﬀecting the drainage rate and amount of Tc-99m sulfur
colloid collected in an SLN), the apparent activity of the node
(AN) in a subset of the 200 patients reviewed was calculated
using the total counts in the injection site (NIS), the total
counts in the SLN (Nn), and the known amount of injected
activity (AIS).
AN = AIS · Nn
NIS
. (1)
Calculations made from regions of interest around SLNs
in the clinical images estimated that the radioactivity in a
typical lymph node was 1.1–1.8 MBq (30–50μCi) of Tc-
99m. This level of activity is consistent with estimates in the
literature [15–17].
2.2. Quantifying Spatial Distortion. Fusion of a lymphos-
cintigram that is, a projection along parallel ray paths—
with a CT to pogram that is, a projection with fan-beam
geometry—is complicated by the inherent misregistration
between the two projection geometries. Topogram geometry
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(A.I) Anterior chest (A.II) Posterior chest
(A.III) Left lateral D1 (A.IV) Right lateral D2
(B.I) Anterior trans
(B.II) Left lateral trans1 (B.III) Right lateral trans2
Figure 1: Traditional breast lymphoscintigraphy technique with 57Co-backlighting for localization. The four images on the left (A.I–A.IV) are
emission images for a bi-lateral lymphoscintigraphic study. The current protocol for localizing sentinel nodes is to backlight the patient using
a 57Co sheet source to create a silhouette of the patient. The anterior (B.I), left lateral (B.II), and right lateral emission + 57Co transmission
images (B.III) are shown on the right.
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Figure 2: Diagram of object magnification and minification for objects in diﬀerent coronal planes relative to isocenter. Topograms diﬀer
from projection radiographs because the topogram is calibrated such that a “virtual” detector lies at a plane through the isocenter. The gray
arrow represents a real object that is projected to isocenter during topogram reconstruction. This reconstruction technique causes objects
that are physically closer to the X-ray source, relative to the gantry isocenter, to appear larger in the image, and vice versa when the object
is physically closer than isocenter to the detectors (unlike projection radiographs, where objects closest to the detector are least aﬀected by
distortion).
diﬀers from the geometry of projection radiographs because
a “virtual” detector lies at a plane through isocenter for
the acquisition of topograms. As in projection radiography,
the fan-beam geometry causes objects closer to the x-ray
source than the gantry isocenter to appear magnified laterally
in the detected image. Unlike radiographs, where objects
closest to the detector appear less distorted in the image
than objects closer to the x-ray source, objects in topogram
acquisitions that are closer to the x-ray detectors than the
gantry isocenter will appear smaller in the image due to
reconstruction software for topograms. Figure 2 summarizes
the various situations leading to spatial distortion.
The spatial distortion due to the geometry of the fan-
beam aﬀects the location of objects in the topogram in both
the anteroposterior and lateral directions. There is no
distortion along the long axis of the patient because the CT
topogram beam is tightly collimated so the edges are nearly
parallel in the cranio-caudal direction. As a special case, small
objects at the isocenter of the gantry remain at the center
of the imaging plane and suﬀer minimal magnification and
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geometric distortion in contrast to objects located away from
the gantry isocenter.
The amount of magnification in the lateral direction
varies as a function of the distance of the coronal plane (of
a supine patient) to the gantry isocenter axis. For vertical
planes perpendicular to the patient couch (sagittal planes
of a supine patient), the lateral distortion is the diﬀerence
between the actual lateral distance of an object relative to
the gantry isocenter and the measured lateral distance of
that object to the central axis of the image. The degree of
magnification and geometric distortion of that object varies
as a function of the distance of the sagittal plane to the gantry
isocenter axis.
To compute the magnitude of the distortion of objects
at diﬀerent coronal and lateral distances (assuming a
supine patient orientation), a point source phantom was
constructed. Six 1.5 mm diameter skin markers used for
mammography, consisting of a metal bead with adhesive tab,
were positioned along one surface at 2.5 cm, 5.0 cm, 10 cm,
15 cm, and 20 cm from the center of a fillable sheet source
phantom. The central axis of the rigid phantom was aligned
with the gantry lasers of the SPECT/CT scanner and the
height of the table was initially adjusted so that the center
of the beads was at the isocenter. Topograms of the phantom
were acquired at diﬀerent table heights between 6.7 cm and
14.0 cm, including the table height position corresponding
to the beads at isocenter (table position = 0 cm). The spatial
distortion of point objects at diﬀerent anteroposterior and
lateral positions was quantified by using the digital ruler tool
in the gamma camera workstation software (e.soft, Siemens
Medical Solutions USA, Hoﬀman Estates, IL) to measure
the lateral distance of the bead from the gantry isocenter
axis in the topogram image. The lateral distortion (or oﬀset)
for each point was computed as the diﬀerence between
the measured distance and the known distance from the
isocenter axis.
2.3. Topogram Localization Protocol for
Breast Lymphoscintigraphy
2.3.1. Acquisition Workflow. The camera is configured with
the detectors in a 180 degree, opposed-view orientation and
static images are acquired in SPECT mode at zero and 90
degree gantry positions. The resulting four images (anterior,
posterior, left lateral, and right lateral) are saved as separate
static DICOM images in the same series. The emission
images are acquired in a 256 × 256 matrix for ten-minutes
per view at each camera position. Posterior/anterior (PA) and
ipsilateral topograms are acquired using a 110 kVp, 20 mA
beam. As patients on a SPECT/CT scanner would not move
for the lateral images, the position and shape of the breast
tissue are more similar to the configuration that the breasts
will have at the time of surgery than if the patient were to
rotate to the decubitus position for the lateral views [1].
Following image acquisition, the original scintigrams
are adjusted for single-point registration and fusion to
the topogram of the SLN as described below. The lateral
magnification factor is applied to the scintigram to match the
geometry of the topogram so that the fan-beam geometry
of the topogram will remain consistent regardless of the
location of an SLN. The original topogram is output as
a new image series with an NM modality tag (rather
than a CT modality tag) in the DICOM header, since the
image fusion software we used would not permit fusing
planar NM data with CT datasets. Fusion images of each
scintigram/topogram pair are then created for subsequent
review.
2.3.2. Compensation for Geometric Distortion. A computer
program was written in the Interactive Data Language (IDL,
ITT Visual Solutions, Boulder, CO) to automate the process
of adjusting the lateral magnification of each scintigram.
The program was integrated into the image processing
application environment of the gamma camera workstation
(e.soft, Siemens Medical Solutions USA, Hoﬀman Estates,
IL). The program accepts as inputs four DICOM images:
anterior and ipsilateral planar lymphoscintigrams, and pos-
terior/anterior and ipsilateral CT topograms. Assuming that
the central pixel of the image corresponds to the isocenter
of the gantry, the distance from the central pixel to the
SLN in both the anterior and lateral images can be used
to laterally magnify or minify the scintigrams to match
the geometries of the topograms and scintigrams for a
particular node location. The operator manually marks a
desired feature such as an SLN on each of the two orthogonal
lymphoscintigrams. The location of the SLN relative to the
isocenter in the lateral lymphoscintigram is then used to
apply the appropriate lateral magnification factor to the
anterior lymphoscintigram. This is because the degree of
distortion of objects in the posterior/anterior topogram is
dependent upon the coronal plane in which the object lies.
The depth of the SLN in the lateral lymphoscintigram gives
the distance of the coronal plane from the isocenter and
the appropriate amount of distortion correction can then
be applied. A similar process is used to correct the lateral
lymphoscintigram. The location of the node in the anterior
lymphoscintigram provides the oﬀset of the sagittal plane
containing the node relative to the gantry isocenter.
After the magnification factor has been applied, the
program generates two new image series: a series of laterally
stretched lymphoscintigrams and a series of CT topograms
with NM modality tags. In cases where several nodes are
visible and widely scattered, the scintigram can be adjusted
diﬀerently and a separate fused image created for each one of
the nodes. We chose to modify the lymphoscintigram rather
than the topogram so that the geometry of the morphological
information will retain a consistent fan-beam presentation.
2.4. Verification of Geometric Compensation
Accuracy
2.4.1. Point Source Phantom. A rigid-plane phantom was
placed on the patient bed of the hybrid SPECT/CT system
with three 57Co button sources positioned at various lateral
distances from the central axis of the scanner. Static emission
images and CT topograms were acquired in both the anterior
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and lateral views at several bed height positions to take
into account diﬀerent SLN anterior-posterior positions. The
images were processed using the geometric compensation
program and analyzed to compute the residual misregistra-
tion of each point source between the scintigram and the
topogram.
2.4.2. Anthropomorphic Thorax Phantom. In order to have
a reproducible test object, a nuclear medicine anthropo-
morphic phantom (Radiology Support Devices, Inc, Long
Beach, CA) was augmented in order to simulate a breast
lymphoscintigraphy injection site and sentinel lymph nodes
(Figure 3). Fillable spheres (Data Spectrum Corporation,
Chapel Hill, NC), such as those used in the NEMA IEC
Body Phantom, were used to mimic the node and injection
sites. Lymph nodes typically are 4 to 6 mm in diameter.
Therefore, fillable spheres of inner diameter 4.95 mm and
volume 0.063 mL were used to represent SLNs in the
phantom. Initial images of the phantom indicated that the
previously estimated 1.1–1.8 MBq (30–50 μCi) nodal activity,
determined by the chart review, was too high. A total activity
in the node between 37 kBq and 370 kBq (1 and 10 μCi) was
used, leading to a range of activity concentrations from 0.59–
5.9 MBq per mL (16 to 160 μCi per mL). A fillable sphere of
inner diameter 19.79 mm and volume 4.0 mL was used for
the injection site. The sphere used for the injection site was
filled with an absolute activity of 92.5 MBq (2.5 mCi); the
volume concentration for the 4.0 mL sphere is thus 23.1 MBq
per mL (0.625 mCi per mL).
Generally, the distance between the anterior surface of
the breast and the injection site ranges from a few millimeters
for a subcutaneous injection to about 3 cm for a perilesional
injection. The distance between the injection site and the
visualized node in patient studies is highly dependent on the
location of both the tumor and the node, but generally the
lymph node is at the junction of the fatty breast tissue and
chest wall.
Superflab (WFR-Aquaplast, Wyckoﬀ, NY) is a tissue-
equivalent material used in radiation therapy. Because the
material is flexible and its characteristics mimic the scattering
properties of tissue, it was used to simulate superficial tissues
in the construction of the phantom.
The setup for the thorax phantom study consisted of
securing the small spheres directly to the thorax phantom
in the anterior axillary region to represent axillary SLNs and
near the mediastinum to represent internal mammary SLNs.
A 0.5 cm layer of superflab was placed over the small sphere
to cushion the objects when the chest overlay was placed onto
the thorax phantom. The chest overlay and fillable breast
phantoms were placed over the thorax phantom. A cavity just
big enough to accommodate the larger sphere (representing
the injection site) was formed in a layer of 1.0 cm thick
superflab in order to provide a scatter medium for imaging.
An additional 1-2 cm of superflab was added as needed to
provide scatter similar to that seen in the patient studies
of the retrospective chart review for both the anterior and
lateral emission images.
Static emission images and CT topograms were acquired
for both the anterior and lateral views of the thorax phantom.
The images were processed using the geometry compen-
sation program and registered to validate the processing
protocol for phantom images that mimic those of patients.
2.5. Dosimetry for Each Localization Technique
2.5.1. 57Co Backlighting Dosimetry. The photon flux of 57Co
sheet sources is too low for measurement with routinely used
radiographic ion chambers such as a Triad or Radcal because
of the insensitivity of the chambers (chamber volumes are
not suﬃcient to detect the low exposure rate of the sheet
source). The absorbed dose from a 111 MBq (3 mCi) 57Co
sheet source was therefore estimated by measuring the expo-
sure rate using a dose-equivalent ion chamber (Inovision
451B-DE-SI, Fluke, Everett, WA). With the gamma camera
configured for opposed-head imaging at a gantry angle of
zero (i.e., to produce anterior and posterior views of a supine
patient), the sheet source was placed on the face of the
collimator of the posterior (lower) detector. The ion chamber
was placed on the patient couch and centered above the sheet
source. Acrylic blocks were placed around the chamber to
simulate the scatter in the human torso. The meter readings,
in μSv per hour, represent the dose-equivalent rate at that
location. (The 451B-DE-SI conversion factor varies between
0.9 and 1.0 over the range of photon energies present
in this setup). The total absorbed dose for unilateral and
bilateral breast lymphoscintigraphy studies was calculated by
accounting for each view of the study. Unilateral studies had
two transmission images acquired whereas bilateral studies
had three transmission images acquired.
2.5.2. CT Topogram Dosimetry. The topogram localization
images need not be of diagnostic imaging quality. It is most
important that the images provide anatomical landmarks
by depicting bony anatomy and providing some soft tissue
information. Topograms of the anthropomorphic phantom
were acquired at 80, 110, and 130 kVp for various mA
settings. The images were presented to two physicians
who assessed image quality with respect to the ability
to adequately localize the hot spheres when fused to the
lymphoscintigrams. Anterior and lateral topograms acquired
at 110 kVp and 20 mA were deemed to be of suﬃcient quality
for SLN localization.
The dosimetry for the topogram localization technique
was estimated using a 6 cubic centimeter cylindrical ion-
ization chamber (Model 10X5-6) and electrometer (Model
9010) (Radcal Corporation, Monrovia, CA) as described by
O’Daniel et al. [18]. The chamber was centered in the gantry
of the CT scanner with the stem of the ion chamber (the
long axis of the cylinder) parallel to the long axis of the
couch. In-air exposure measurements were recorded for both
the anterior/posterior (AP) and posterior/anterior (PA) tube
positions. The entrance skin exposure was calculated for
an average size patient (23 cm anterior-posterior thickness)
for each tube position by correcting the isocenter exposure
measurement using the inverse-square method. The skin
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Thorax phantom
Microspheres
Thin superflab
Thorax overlay and
breast phantoms
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Thick superflab
Figure 3: Phantom Setup for Breast Lymphoscintigraphy Studies. The micro spheres used to represent the lymph nodes are applied directly
to the surface of the thorax phantom. 0.5 cm of thin superflab is placed over the nodes, then the chest overlay and breast phantoms are
positioned. The 4.0 mL sphere used for the injection site is then embedded in a 2-3 cm thick piece of superflab that is placed on one of the
breast phantoms.
dose was calculated using the Roentgen-to-rad conversion
(0.87 rad = 1 R and for SI units 1 rad = 10 mGy) and
back-scatter factor (assumed to be 1.35) [19]. In order to
properly convert the skin dose measurements to eﬀective
dose, a conversion factor of 0.1 mSv per mGy was obtained
from the National Radiological Protection Board Report W4
[19].
2.5.3. Computed Tomography (CT) Dosimetry. If CT
tomographic images are to be used only to localize SLNs, the
CT need not be of diagnostic quality and should be acquired
at a relatively low dose (i.e., low mAs). For the purposes
of this study, five diﬀerent scan parameter combinations
were tested to assess the range of absorbed doses that
might be delivered to the patient: 130 kVp, 90 mAs; 130 kVp,
20 mAs; 110 kVp, 20 mAs; 110 kVp, 10 mAs; and 80 kVp,
20 mAs.
The CT dose index (CTDI) dosimetry method employs
a CTDI body phantom (Model 20CT14) and a 10 cm
long, 3 cubic centimeter pencil ionization chamber (Model
10X5-3CT) (Radcal Corporation, Monrovia, CA) [20]. In-
phantom measurements of exposure (mR) were recorded for
the central chamber position and four peripheral positions.
Then, CTDI100, CTDIw, CTDIvol, and dose-length product
(DLP) values were calculated according to the definitions
in American Association of Physicists in Medicine (AAPM)
Report Number 96 [21], using a detector configuration of
6 × 2 mm and pitch of 1.2. The DLP (based on 40 cm scan
length) for a given CT scan was converted to eﬀective dose
using the conversion factors in the European Guidelines
on Quality Criteria for Computed Tomography [22]. Since
the localization technique for the breast lymphoscintigraphy
protocol has a scan extent throughout the chest region, the κ-
factor used for this estimation of eﬀective dose was 0.017 mSv
per mGy-cm.
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Figure 4: Measured spatial distortion of CT topogram. The error
in lateral distance from isocenter (measured-true) of a point object
(mammography bead) varied linearly as a function of both the
lateral and coronal distance from isocenter.
3. Results
3.1. Topogram Spatial Distortion. The measured spatial mis-
match between uncompensated scintigrams and topograms
increased linearly with distance from the isocenter in the
anterior-posterior and lateral directions (Figure 4). The
range of measured spatial oﬀset was from 0.0 to 4.4 cm. The
measured distance (x) of the point sources from the long
axis of the topogram when the point source is in a given
coronal plane (β) can be approximated by (2). The actual
lateral distance of the point source from the long axis of the
hybrid scanner is denoted by α
x[cm] = (0.08β + 4.98) ·
(
α
5 cm
)
. (2)
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The measured spatial mismatch is calculated by the diﬀer-
ence of the measured position of the point source, x, and the
actual lateral position of the point source from the central
axis of the scanner, α. The spatial mismatch is estimated by
x[cm]− α[cm] = (0.016β− 0.004) · (α). (3)
3.2. Verification of the Geometric Compensation
3.2.1. Point Source Phantom. The misregistration between
nuclear medicine scintigrams and CT topograms was
reduced to within ±3.4 mm in the plane of a particular 57Co
button source. The residual misregistration is less than the
intrinsic resolution of the gamma camera (3.2–3.4 mm) and
much less than the overall system resolution of the images.
Fused images of the registered, geometrically compensated
scintigrams, and topograms of the point source phantom
are shown in Figure 5. As the lateral magnification of the
topogram is processed separately for each individual object
of interest, only the indicated point source is correctly
registered since each source is in a diﬀerent sagittal plane.
3.3. Anthropomorphic Thorax Phantom. In addition to mea-
suring the spatial distortion of topograms by using a
point-source phantom, the anthropomorphic thorax phan-
tom was used for qualitative comparison of various lym-
phoscintigraphic imaging methods. The phantom studies
were performed to visually compare our proposed method
of localization to the conventional method (Figure 6). The
direct comparison of the two techniques illustrates how
much additional information is provided by our approach
with respect to localizing an SLN relative to bony anatomy.
3.4. Dosimetry
3.4.1. 57Co Backlighting. The measured dose rate for a
111 MBq (3 mCi) sheet source was 87 uSv per hour. If
the 57Co backlit images were acquired for 3 minutes per
view, then the estimated eﬀective dose for unilateral and
bilateral breast lymphoscintigraphy studies localized with
the backlighting technique would be 9 μSv and 13 μSv,
respectively.
3.4.2. Topogram Localization. The measured in-air exposure
at gantry isocenter for a 110 kVp, 20 mA PA topogram
was 18 mR, so the exposure at the skin surface would be
19 mR using an inverse-square correction. The estimated
skin dose for the CT topogram is 0.23 mGy. Using the
0.1 mSv per mGy conversion from skin dose to eﬀective dose,
the estimated eﬀective dose for the 110 kVp, 20 mA topogram
would be 22.5 μSv. NRPB-W4 does not provide an mSv per
mGy conversion from skin dose to eﬀective dose for lateral
exams. However, based on several other known acquisition
techniques and configurations, it is reasonable to expect that
the eﬀective dose for the lateral topogram would be only one
order of magnitude greater than the estimated dose using
57Co backlighting (Table 1).
3.4.3. CT Localization. The eﬀective dose to the chest for a
CT scan ranged from 0.308 mSv for the lowest possible dose
setting (80 kVp, 20 mAs) to 5.265 mSv for the default clinical
CT scan setting (130 kVp, 90 mAs). The calculations for each
dose index, the DLP, and the eﬀective dose for each of the CT
scan parameter combinations are compiled in Table 2.
4. Discussion
The fusion of a geometry-compensated lymphoscintigram
with a CT topogram is a new method of anatomical
localization for lymphoscintigraphy. When compared to the
time-honored means of localization using backlighting with
a 57Co sheet source, it oﬀers a substantial increase in both
the number and detail of anatomical references at the relative
detriment of an order of magnitude increase in the still
quite modest absorbed dose to the patient. Furthermore, the
gantry of the SPECT/CT camera can be rotated to acquire
the lateral topogram and the lateral scintigrams while the
patient does not move. Thus all of the views may be acquired
without moving the patient from a position close to that in
which subsequent biopsy or surgery would be performed.
While a full CT exam would avoid the need for geometrical
compensation, it would impose a further increase of one
to two orders of magnitude over our proposed approach in
absorbed dose to the patient.
The software program used to adjust the scintigrams was
written in IDL in such a fashion that it functions stand-alone
or it can be incorporated into a vendor image processing
workstation using workflow “broker activities.” The image
registration and fusion of the stretched scintigrams with
“NM” DICOM tags and CT topograms with “NM” DICOM
tags can be performed with any vendor software program
that registers and fuses two planar nuclear medicine (NM)
images. Although the IDL program was integrated into the
Siemens E.Soft image processing workstation for this project,
the images were also fused successfully using OsiriX (Pixmeo,
Switzerland).
The most fruitful cases in which to conduct the first
clinical evaluations of this technique would be in regions of
the body of moderate complexity such as for drainage to the
internal mammary lymphatic chain, where the surgeon must
know which rib to remove in order to access a given node.
Extremely complex anatomy, such as the head and neck, calls
for a full SPECT/CT study, while in cases of drainage to
the axillary lymphatic chain, the plasticity of the tissues and
the absence of skeletal interference to the surgical approach
make the improvement of topogram fusion over sheet source
backlighting of less value.
5. Conclusion
Gamma camera images of the phantom described herein are
realistic-looking surrogates for actual patient lymphoscinti-
grams. The phantom meets the need for a reproducible
object in which the true location and activity of a simulated
lymph node is known.
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(a) (b)
Figure 5: Accuracy of lateral distortion compensation algorithm for planar scintigram-CT topogram registration. Fused images of the
original (uncompensated) scintigram and CT topogram of three button sources (a), and stretched (compensated) scintigram and CT
topogram (b). The vertical shift in the original fused images is due to a registration oﬀset in the table travel direction of the scanner equal to
the distance between the edge of the field of view of the gamma camera detector and the edge of the image matrix. This oﬀset is accounted
for in the compensation algorithm so the scintigram and topogram accurately register in the longitudinal direction of the scanner. On the
right, the scintigram is compensated to correct the lateral position of the right-most button source. The residual error in lateral position of
a given button source after compensation was within ±3.44 mm.
Anterior emission Anterior transmission Anterior emission w/topogram localization
(a)
Lateral emission Lateral transmission Lateral emission w/topogram localization
(b)
Figure 6: Comparison of scintigram-CT topogram method to conventional lymphoscintigraphy. Anterior (a) and lateral (b) views of ten-
minute emission images, conventional localization images, and planar scintigrams fused with CT topograms, of an anthropomorphic thorax
phantom with a simulated internal mammary SLN. The current acquisition and processing workflow provides the physician with a visual
comparison of the conventional and proposed method of localization. The anterior view of the scintigram-topogram fused image (a-right)
provides location information for the internal mammary lymph node relative to the ribs and sternal notches.
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Table 1: Measured exposure and calculated CT topogram dose versus kV and mA. For topogram acquisitions, three conversion factors
(Rontgen-to-mGy, backscatter factor, and skin dose-to-eﬀective dose) are used to estimate the eﬀective dose for several techniques of
topogram acquisition.
KV mA Time [s] Tube position Measured exposure (in-air) [mR] Skin dose [mGy] Eﬀective dose (NRPB-W4) [mSv]
130 20 3.1
Top (A/P) 32.29 0.40 0.040
bottom (p/A) 25.91 0.32 0.032
110 20 3.1
top (A/p) 23.19 0.28 0.028
Bottom (P/A) 18.36 0.23 0.023
80 20 3.1
Top (A/P) 12.72 0.16 0.016
Bottom (P/A) 9.78 0.12 0.012
Table 2: Measured exposure and calculated CT dose versus kVp and mAs. In CT scans, the CTDIvol and DLP values are used to convert
in-phantom ion chamber measurements to estimated eﬀective dose in the standard CT dosimetry phantoms (μSv).
KVp mAs location Exposure [R] CTDI vol [mGy] DLP [mGy∗cm] Eﬀective dose [mSv]
80 20
center 0.00395
0.453 18.137 0.308
Periphery 0.00928
110 10
center 0.00588
0.576 23.057 0.392
Periphery 0.01137
110 20
center 0.01177
1.153 46.115 0.784
Periphery 0.02274
130 20
center 0.01791
1.720 68.818 1.170
Periphery 0.03376
130 90
center 0.08059
7.742 309.681 5.265
Periphery 0.15192
We demonstrated that fusing lymphoscintigrams to CT
topograms is superior to 57Co backlighting for produc-
ing detailed anatomic localization images. Through our
approach, simulated lymph nodes in anterior and lateral
scintigrams can be localized to within ±3.4 mm between the
fused scintigram and topogram. This misregistration error
is less than the intrinsic resolution, and much less than
the system compound resolution, of the gamma camera for
lymphoscintigraphic imaging.
Moreover, for many clinical applications, fusion of a
planar scintigram with a CT topogram may oﬀer the best
compromise between absorbed dose to the patient and
critical anatomic detail.
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